Page 4 - Randomised Evaluation News Today

Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studiesThe European Commission is expected to make a final decision regarding approval

06.12.2021 - Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase III studiesThe European Commission is expected to make a final decision regarding approval in the near future Basel, 06 December ... Seite 1

In a meta-analysis of six studies evaluating colchicine as a COVID-19 treatment, the anti-inflammatory drug for acute gout attacks did not appear to improve outcomes for patients.

The huge improvements in COVID-19 outcomes among critical care patients thanks to innovative trials and adaptive working practices could be lost if key lessons are not learned, warns UK clinician.

ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation The trial, India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy), will be a multi-centre, adaptive platform trial on COVID patients, ICMR said on Friday. Outlook Web Desk 10 July 2021, Last Updated at 11:42 am PTI Outlook Web Desk 2021-07-10T11:11:35+05:30 ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation outlookindia.com 2021-07-10T11:42:22+05...

06 Jun 2021 / 07:14 H. KUALA LUMPUR: The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals. Health director-general Tan Sri Dr Noor Hisham Abdullah (pix) said Ivermectin is a Food and Drug Administration (FDA) approved antiparasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and ...

KUALA LUMPUR, June 5 — The Ministry of Health (MOH) and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 MOH’s hospitals. Health director-general Tan Sri Dr Noor Hisham Abdullah said...

KUALA LUMPUR (Bernama): The Health Ministry and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk Covid-19 patients at 12 of the ministry's hospitals.

Why India finally scrapped plasma as Covid treatment, 7 months after ICMR said it doesn’t work Abantika Ghosh © Provided by The Print New Delhi: It was exactly seven months ago that Dr Balram Bhargava, director general of the Indian Council of Medical Research (ICMR) first announced that India is planning to remove plasma therapy as a Covid-19 treatment option. An ICMR study found that infusing blood plasma from a recovered patient showed no significant benefits on a patient...

India made two crucial changes to its Covid treatment protocol, both were prompted by the research done in the UK and published in the reputed medical journal The Lancet.